MLL4 Antibody (C-term) Blocking Peptide

MLL4 Antibody (C-term) Blocking Peptide

€363.00
In stock
SKU
AC-BP6185a
Catalog Number: AC-BP6185a
Size: 500 µg
Datasheet
Request Information
Background:
MLL4 contains multiple domains including a CXXC zinc finger, three PHD zinc fingers, two FY-rich domains, and a SET (suppressor of variegation, enhancer of zeste, and trithorax) domain. The SET domain is a conserved C-terminal domain that characterizes proteins of the MLL (mixed-lineage leukemia) family. This gene is ubiquitously expressed in adult tissues. It is also amplified in solid tumor cell lines, and may be involved in human cancer.

Other Names:
Histone-lysine N-methyltransferase 2B, Lysine N-methyltransferase 2B, Myeloid/lymphoid or mixed-lineage leukemia protein 4, Trithorax homolog 2, WW domain-binding protein 7, WBP-7, KMT2B, HRX2, KIAA0304, MLL2, MLL4, TRX2, WBP7

Target/Specificity:
The synthetic peptide sequence used to generate the antibody AP6185a was selected from the C-term region of human MLL4 . A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.

Gene Name: KMT2B

Gene ID: 9757
Primary Accession: Q9UMN6
Other Accession: NP_055542
Format: Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.
More Information
Is Featured? No
Write Your Own Review
You're reviewing:MLL4 Antibody (C-term) Blocking Peptide